Skip to content
OpenCapital
Get started

Johnson & Johnson JNJ MedTech — Indefinite-lived trademarks

Similar metrics at other companies

McCormick & Company, Incorporated logo
MKCIndefinite-lived intangible assets, total
$8.35B+1.0%
IR
IRMedical — Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
$3.7M—
Stanley Black & Decker logo
SWKLenox, Troy-Bilt, Irwin Trade Names — Indefinite-lived trade names
$119.6M—
GameStop logo
GMEUnited  States — Indefinite-lived intangible assets
$0—
Revvity logo
RVTYHuman Health — Indefinite Lived Intangible Assets Excluding Goodwill
$0—
Chart Industries logo
GTLSBiomedical — Intangible Impairment
$9.53M—

Other financials

Income statement

See full
Revenue$24.1B+9.9%
Gross profit$16.0B+9.8%
Operating income$6.3B+2.3%
Net income$5.2B-52.4%
EPS (diluted)$2.14-52.9%

Balance sheet

See full
Cash & equivalents$21.7B-43.6%
Total debt$55.0B+5.2%
Total equity$81.2B+3.9%
Total assets$200.89B+3.7%

Cash flow

See full
Operating cash flow$2.5B-39.8%
CapEx$1.0B+31.9%
Free cash flow$1.5B-56.6%

Valuation

See full
Market cap$549.78B+47.3%
Enterprise value$583.08B+50.5%
P/E26.1×+9.0×
P/S5.7×+1.5×

Profitability

See full
Gross margin67.8%-0.5pp
Operating margin26.4%+2.8pp
Net margin21.8%-2.6pp
FCF margin18.5%-4.3pp

Returns & leverage

See full
Return on equity26.4%-3.0pp
Debt / equity0.7×0.0×
Current ratio1×-0.2×

Where this comes from

Reported directly by Johnson & Johnson in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedTrademarks.

The official record: Johnson & Johnson’s 10-K, filed February 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Johnson & Johnson's medtech — indefinite-lived trademarks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Johnson & Johnson's medtech — indefinite-lived trademarks?
Johnson & Johnson (JNJ) reported medtech — indefinite-lived trademarks of $1.7B in Q4 2025.
What does medtech — indefinite-lived trademarks mean?
The total book value of brand trademarks that are expected to provide value to the company indefinitely.
How do you interpret medtech — indefinite-lived trademarks?
An increase suggests successful brand acquisitions or revaluation, while a decrease may indicate impairment charges or the divestiture of key product lines.
How does medtech — indefinite-lived trademarks compare across companies?
Peers in the medical device industry typically report these under intangible assets, often reflecting the strength of acquired intellectual property and brand portfolios.